During the past decade, Gachon University Gil Medical Center conducted 245 clinical trials. In the 10-year time frame, 245 clinical trials started and 84 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 54 clinical trials were completed. i.e. 63.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gachon University Gil Medical Center" #1 sponsor was "Gachon University Gil Medical Center" with 48 trials, followed by "Hoffmann-La Roche" with 24 trials sponsored, "Pfizer" with 22 trials sponsored, "Seung-Jung Park" with 15 trials sponsored and "Boehringer Ingelheim" with 15 trials sponsored. Other sponsors include 249 different institutions and companies that sponsored additional 146 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gachon University Gil Medical Center" #1 collaborator was "CardioVascular Research Foundation, Korea" with 17 trials as a collaborator, "Eli Lilly and Company" with 9 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 8 trials as a collaborator, "Gachon University Gil Medical Center" with 6 trials as a collaborator and "Incyte Corporation" with 5 trials as a collaborator. Other collaborators include 216 different institutions and companies that were collaborators in the rest 156 trials.

According to Clinical.Site data, the most researched conditions in "Gachon University Gil Medical Center" are "Coronary Artery Disease" (17 trials), "Multiple Myeloma" (12 trials), "Breast Cancer" (11 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials) and "Alzheimer's Disease" (7 trials). Many other conditions were trialed in "Gachon University Gil Medical Center" in a lesser frequency.

Most popular intervention types in "Gachon University Gil Medical Center" are "Drug" (298 trials), "Other" (29 trials), "Device" (28 trials), "Biological" (25 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (80 trials), "Docetaxel" (9 trials), "Paclitaxel" (9 trials), "Atezolizumab" (8 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Gachon University Gil Medical Center" are 355 trials for "All" genders, 16 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Gachon University Gil Medical Center". undefined are not yet recruiting, 65 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 175 completed trials in Gachon University Gil Medical Center, undefined suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Gachon University Gil Medical Center, 30 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 159 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 23 trials that are defined as “Not Applicable".